Your session is about to expire
← Back to Search
Methionine Imaging for Cancer Detection
Phase 2
Waitlist Available
Led By Barry L Shulkin, MD
Research Sponsored by St. Jude Children's Research Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study (maximum of 3 years post methionine infusion and pet scan)
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing the usefulness of imaging with radiolabeled methionine to find tumors in children and young adults.
Who is the study for?
This trial is for children and young adults with various types of cancer, including brain tumors and sarcomas. Participants can be any age or gender, must not be breastfeeding if they are of childbearing age, have consented to the study, and are under the care of St. Jude physicians.
What is being tested?
The trial is testing a diagnostic imaging technique using C-11 methionine (MET) with PET/CT scans to evaluate tumor presence and response to therapy in patients with malignant solid neoplasms, focusing on CNS tumors and sarcomas.
What are the potential side effects?
Since this trial involves diagnostic imaging rather than medication or treatment intervention, side effects may include exposure to radiation. However, specific side effects related to MET PET/CT scans are not detailed.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ end of study (maximum of 3 years post methionine infusion and pet scan)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study (maximum of 3 years post methionine infusion and pet scan)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Success rate of methionine (MET) for visualizing tumors
Secondary study objectives
Association of methionine uptake with tumor grade
Bio-distribution of MET in organs
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: ParticipantsExperimental Treatment1 Intervention
Participants who meet the eligibility criteria in the study will receive methionine.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Methionine
2019
Completed Phase 2
~10
Find a Location
Who is running the clinical trial?
St. Jude Children's Research HospitalLead Sponsor
443 Previous Clinical Trials
5,304,831 Total Patients Enrolled
Barry L Shulkin, MDPrincipal InvestigatorSt. Jude Children's Research Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had, or will have, a scan like PET, CT, or MRI within the next 4 weeks.I am not breastfeeding as I might need to undergo treatments involving radiation.My age or gender does not affect my eligibility.
Research Study Groups:
This trial has the following groups:- Group 1: Participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger